← Back to patent-cliff list
Viroxavir marboxil
Tier C — Watch / tradeViroxavir marboxil
Traws Pharma Inc
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：Endonucleases
Indications (approved)：Influenza virus infection
Regional status
US
Phase I
2024-03-01
EU
Phase II
2026-06-01
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Viroxavir marboxil?
Approved indications include: Influenza virus infection.
When does the Viroxavir marboxil patent expire?
No public expiry year is available for Viroxavir marboxil yet; this page updates once verified.
How do I get a quote for Viroxavir marboxil intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-29